Gastrointestinal Cancers
33
9
11
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
3 terminated out of 33 trials
78.6%
-8.0% vs benchmark
9%
3 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (33)
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
PRecision Oncology CUhk pRogrammE (PRO-CURE)
Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal Cancers
Personalized Health Self-Management Training for Colorectal Cancer Survivors
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery
A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies
Feasibility Study of CBCT for IGRT in Cancer Patients
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
Sex Differences in Gastrointestinal Cancer Surgery